135 related articles for article (PubMed ID: 7116689)
1. Reversal of immune complex inhibition of antibody-dependent cell-mediated cytotoxicity by normal human serum.
Isturiz MA; Fink SB; de Bracco MM
Clin Exp Immunol; 1982 Jun; 48(3):685-92. PubMed ID: 7116689
[TBL] [Abstract][Full Text] [Related]
2. Effect of rheumatoid factors and normal human sera on immune complex-Fc gamma R interaction.
Isturiz MA; Giordano M; Serebrinsky GP
Clin Exp Immunol; 1983 Oct; 54(1):225-31. PubMed ID: 6225582
[TBL] [Abstract][Full Text] [Related]
3. Normal human serum restores the expression of Fc gamma receptors in immune complex-blocked human mononuclear cells.
Geffner JR; Serebrinsky G; Isturiz MA
Immunology; 1986 Oct; 59(2):239-43. PubMed ID: 2945776
[TBL] [Abstract][Full Text] [Related]
4. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
[TBL] [Abstract][Full Text] [Related]
5. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphocyte and monocyte antibody-dependent cellular cytotoxicity by immune complexes: effect of normal human serum.
Geffner JR; Giordano M; Serebrinsky GP; Palermo MS; Isturiz MA
Immunol Lett; 1987 Jul; 15(3):255-9. PubMed ID: 2959617
[TBL] [Abstract][Full Text] [Related]
7. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
Pham Huu T; Buriot D; Griscelli C
Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.
Walker L; Hay FC; Roitt IM
Clin Exp Immunol; 1979 Jun; 36(3):397-407. PubMed ID: 487643
[TBL] [Abstract][Full Text] [Related]
9. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.
Poston RN; Morgan RS
Immunology; 1983 Nov; 50(3):461-9. PubMed ID: 6629417
[TBL] [Abstract][Full Text] [Related]
10. Different activation pathways involved in antibody-dependent and immune-complexes-triggered cytotoxicity mediated by neutrophils.
Geffner JR; Giordano M; Serebrinsky G; Isturiz MA
Clin Exp Immunol; 1988 Dec; 74(3):471-6. PubMed ID: 2853017
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
Medof ME; Prince GM; Oger JJ
Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of antibody-dependent, cell-mediated cytotoxicity by serum from lepromatous leprosy patients.
de la Barrera SS; Sasiain MC; Geffner J; Isturiz MA; Segal-Eiras A; de Bracco MM
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):218-24. PubMed ID: 4020209
[TBL] [Abstract][Full Text] [Related]
13. Reversal of antibody-dependent cellular cytotoxicity suppression by cycloheximide.
Serebrinsky G; Isturiz MA
Immunology; 1985 Oct; 56(2):245-51. PubMed ID: 4054944
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
Howat JM; Moore M; Hilton AM; Kimber I
Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
[TBL] [Abstract][Full Text] [Related]
15. Effect of proteolytic enzymes on neutrophil Fc gamma RII activity.
Trevani AS; Andonegui GA; Isturiz MA; Schatner M; Serebrinsky G; Geffner JR
Immunology; 1994 Aug; 82(4):632-7. PubMed ID: 7835928
[TBL] [Abstract][Full Text] [Related]
16. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of complement-dependent phagocytosis by monocytes following pre-incubation with immune complexes and interaction with plasma.
Pinching AJ
Clin Exp Immunol; 1983 Jan; 51(1):83-90. PubMed ID: 6831773
[TBL] [Abstract][Full Text] [Related]
18. Immune complex-dependent T cell-mediated cytostasis (IDTC).
Tanaka J; Yata J
Clin Exp Immunol; 1981 Jul; 45(1):215-23. PubMed ID: 6975682
[TBL] [Abstract][Full Text] [Related]
19. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
Ferrante A; Rowan-Kelly B
Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
[TBL] [Abstract][Full Text] [Related]
20. Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes.
Kávai M; Sándor M; Szegedi G; Füst G; Gergely J
Immunology; 1981 Nov; 44(3):599-606. PubMed ID: 7033117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
